Industry Research Reports
Home > Reports > Chemical & Material > Global Iohexol Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Iohexol Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-10-29
Pages: 131 Pages
Report ld: 5290170
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Iohexol Market Size(US$)
CAGR 2025-2031
6.9%
Market Size,2031
USD 1,073
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 719 million
Market Forecast in 2031(Value)
US$ 1,073 million
CAGR
6.9%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Iohexol market is projected to grow from US$ 674 million in 2024 to US$ 1073 million by 2031, at a CAGR of 6.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Iohexol is a non-ionic, iodinated radiocontrast agent used to enhance visibility of anatomical structures in X-ray based imaging procedures (CT, angiography, myelography, urography, joint studies and other contrast-enhanced scans). The active pharmaceutical ingredient (API) — chemically an organoiodine compound — is supplied to formulators of finished contrast media (sterile injectable solutions, oral/rectal solutions for bowel studies, or intrathecal preparations) and, in some cases, to manufacturers of specialty laboratory reagents that use iodinated density media. In commercial terms the “Iohexol API market” therefore covers: production and sale of technical- and pharmaceutical-grade Iohexol (including batches certified to pharmacopeial standards); regulatory documentation such as Drug Master Files (DMFs) and certificates of analysis supplied to finished product manufacturers; contract manufacturing (CMO) and custom synthesis for brand and generic contrast media producers; and the downstream finished-dosage contrast media market that ultimately consumes the API.
Iohexol sold into the pharmaceutical channel must meet stringent purity, identity, and particulate/sterility standards appropriate for parenteral use; producers commonly supply documentation aligned with pharmacopeial monographs and regulatory expectations for injectable contrast media. Because finished contrast products are administered intravenously, intrathecally, or orally for diagnostic imaging, the API’s manufacturing process, residual solvent profile, heavy-metal content, and impurity profile are central to market acceptability. Compliance with pharmacopeial monographs and the ability to support regulatory filings (e.g., provision of a US DMF, CEP for EU markets, or equivalent dossiers) are usual entry barriers for suppliers.
In 2024, global Iohexol production reached approximately 5,545.5 MT, with an average global market price of around US$ 121.5 per kg. The global single-line production capacity ranges from 500 to 800 MT per year. The industry's gross profit margin is approximately 35%-45%.
Demand for Iohexol is driven by the global use of contrast-enhanced imaging in hospitals, outpatient imaging centers, interventional radiology, cardiology suites, and surgical planning. The primary use is in computed tomography (CT) angiography and general CT imaging to delineate blood vessels, organs, and lesions; it is also used in intrathecal myelography and specialized procedures. Growth drivers on the demand side typically include expansion of medical imaging capacity (new CT installations and interventional suites), ageing populations with higher imaging utilization, rising incidence and detection of chronic diseases (cardiovascular disease, cancer), and broader adoption of minimally invasive image-guided procedures that require high-quality contrast agents. In many clinical pathways, contrast media are integral to diagnostic accuracy, so demand is relatively inelastic to small price fluctuations — although procurement practice and tendering by hospitals, health systems, and large distributors can exert strong price pressure.
The Iohexol market is a technically and regulatory-intensive niche within the broader contrast media and radiopharmaceutical supply chain. Its demand is underpinned by durable clinical needs — diagnostic CT and image-guided procedures — with steady growth driven by demographic changes and expanding global imaging capacity. Market developments will be shaped by: regulatory expectations (pharmacopeial alignment, DMFs), procurement behavior (tendering and generic competition), supplier capability (GMP/DMF/CEP credentials), and regional investment in imaging infrastructure. While substitution risk is limited for many CT applications, cost pressure, supply reliability, and environmental/regulatory compliance will continue to drive supplier consolidation, vertical integration, and selective capacity investments. For new entrants, the combination of capital-intensive quality systems and the need to support regulatory dossiers makes the market accessible mainly to established API manufacturers or CMOs that can rapidly meet pharmacopeial and regulatory demands.
Global key manufacturers of Iohexol include GE Healthcare, Otsuka Chemicals, Starry, etc. Global top three manufacturers hold a share about 85%.
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Iohexol market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Zhejiang Hichi Pharmaceutical
- GE Healthcare
- Zhejiang Starry Pharmaceutical
- Otsuka Chemicals
- Justesa Imagen
- Beijing Beilu Pharmaceutical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Original Drug
- Generic Drug
Segment by Application
- Contrast Agents
- Diagnostic Agents
- Others
Segment by Category
- Pharmaceutical Grade (GMP-Grade)
- Technical or Laboratory Grade
- Custom Purity Grades
Segment by Division
- Standard Assay (≥ 99.0%)
- High Assay (≥ 99.5%)
- Research or Technical Grade (≥ 97–98%)
CHAPTER OUTLINE
Chapter 1: Defines the Iohexol study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Iohexol: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Iohexol Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Original Drug
1.2.3 Generic Drug
1.3 Market Segmentation by Application
1.3.1 Global Iohexol Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Contrast Agents
1.3.3 Diagnostic Agents
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Iohexol Revenue Estimates and Forecasts 2020-2031
2.2 Global Iohexol Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Iohexol Sales Estimates and Forecasts 2020-2031
2.4 Global Iohexol Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Iohexol Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
4 Competition by Manufacturers
4.1 Global Iohexol Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Iohexol Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Original Drug Market Size by Manufacturers
4.5.2 Generic Drug Market Size by Manufacturers
4.6 Global Iohexol Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Iohexol Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Iohexol Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Iohexol Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Iohexol Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Iohexol Sales and Revenue by Type (2020-2031)
7.4 North America Iohexol Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Iohexol Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Iohexol Sales and Revenue by Type (2020-2031)
8.4 Europe Iohexol Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Iohexol Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Iohexol Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Iohexol Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Iohexol Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Iohexol Sales and Revenue by Type (2020-2031)
10.4 Central and South America Iohexol Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Iohexol Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Iohexol Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Iohexol Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Iohexol Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Zhejiang Hichi Pharmaceutical
12.1.1 Zhejiang Hichi Pharmaceutical Corporation Information
12.1.2 Zhejiang Hichi Pharmaceutical Business Overview
12.1.3 Zhejiang Hichi Pharmaceutical Iohexol Product Models, Descriptions and Specifications
12.1.4 Zhejiang Hichi Pharmaceutical Iohexol Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Zhejiang Hichi Pharmaceutical Iohexol Sales by Product in 2024
12.1.6 Zhejiang Hichi Pharmaceutical Iohexol Sales by Application in 2024
12.1.7 Zhejiang Hichi Pharmaceutical Iohexol Sales by Geographic Area in 2024
12.1.8 Zhejiang Hichi Pharmaceutical Iohexol SWOT Analysis
12.1.9 Zhejiang Hichi Pharmaceutical Recent Developments
12.2 GE Healthcare
12.2.1 GE Healthcare Corporation Information
12.2.2 GE Healthcare Business Overview
12.2.3 GE Healthcare Iohexol Product Models, Descriptions and Specifications
12.2.4 GE Healthcare Iohexol Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 GE Healthcare Iohexol Sales by Product in 2024
12.2.6 GE Healthcare Iohexol Sales by Application in 2024
12.2.7 GE Healthcare Iohexol Sales by Geographic Area in 2024
12.2.8 GE Healthcare Iohexol SWOT Analysis
12.2.9 GE Healthcare Recent Developments
12.3 Zhejiang Starry Pharmaceutical
12.3.1 Zhejiang Starry Pharmaceutical Corporation Information
12.3.2 Zhejiang Starry Pharmaceutical Business Overview
12.3.3 Zhejiang Starry Pharmaceutical Iohexol Product Models, Descriptions and Specifications
12.3.4 Zhejiang Starry Pharmaceutical Iohexol Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Zhejiang Starry Pharmaceutical Iohexol Sales by Product in 2024
12.3.6 Zhejiang Starry Pharmaceutical Iohexol Sales by Application in 2024
12.3.7 Zhejiang Starry Pharmaceutical Iohexol Sales by Geographic Area in 2024
12.3.8 Zhejiang Starry Pharmaceutical Iohexol SWOT Analysis
12.3.9 Zhejiang Starry Pharmaceutical Recent Developments
12.4 Otsuka Chemicals
12.4.1 Otsuka Chemicals Corporation Information
12.4.2 Otsuka Chemicals Business Overview
12.4.3 Otsuka Chemicals Iohexol Product Models, Descriptions and Specifications
12.4.4 Otsuka Chemicals Iohexol Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 Otsuka Chemicals Iohexol Sales by Product in 2024
12.4.6 Otsuka Chemicals Iohexol Sales by Application in 2024
12.4.7 Otsuka Chemicals Iohexol Sales by Geographic Area in 2024
12.4.8 Otsuka Chemicals Iohexol SWOT Analysis
12.4.9 Otsuka Chemicals Recent Developments
12.5 Justesa Imagen
12.5.1 Justesa Imagen Corporation Information
12.5.2 Justesa Imagen Business Overview
12.5.3 Justesa Imagen Iohexol Product Models, Descriptions and Specifications
12.5.4 Justesa Imagen Iohexol Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Justesa Imagen Iohexol Sales by Product in 2024
12.5.6 Justesa Imagen Iohexol Sales by Application in 2024
12.5.7 Justesa Imagen Iohexol Sales by Geographic Area in 2024
12.5.8 Justesa Imagen Iohexol SWOT Analysis
12.5.9 Justesa Imagen Recent Developments
12.6 Beijing Beilu Pharmaceutical
12.6.1 Beijing Beilu Pharmaceutical Corporation Information
12.6.2 Beijing Beilu Pharmaceutical Business Overview
12.6.3 Beijing Beilu Pharmaceutical Iohexol Product Models, Descriptions and Specifications
12.6.4 Beijing Beilu Pharmaceutical Iohexol Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Beijing Beilu Pharmaceutical Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Iohexol Industry Chain
13.2 Iohexol Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Iohexol Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Iohexol Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Iohexol Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Iohexol Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Iohexol Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Iohexol Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Iohexol Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Iohexol Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Iohexol Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Iohexol Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)
Table 7. Global Iohexol Sales by Region (2020-2025) & (MT)
Table 8. Global Iohexol Sales by Region (2026-2031) & (MT)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Iohexol Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)
Table 11. Global Iohexol Production by Region (2020-2025) & (MT)
Table 12. Global Iohexol Production by Region (2026-2031) & (MT)
Table 13. Global Iohexol Sales by Manufacturers (2020-2025) & (MT)
Table 14. Global Iohexol Sales Share by Manufacturers (2020-2025)
Table 15. Global Iohexol Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Iohexol Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Iohexol by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Iohexol as of 2024)
Table 19. Global Iohexol Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Iohexol Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Kg)
Table 21. Key Manufacturers Iohexol Manufacturing Base and Headquarters
Table 22. Global Iohexol Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Iohexol Sales by Type (2020-2025) & (MT)
Table 26. Global Iohexol Sales by Type (2026-2031) & (MT)
Table 27. Global Iohexol Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Iohexol Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Iohexol ASP by Type (2020-2031) & (US$/Kg)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Iohexol Sales by Application (2020-2025) & (MT)
Table 32. Global Iohexol Sales by Application (2026-2031) & (MT)
Table 33. Iohexol High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Iohexol Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Iohexol Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Iohexol ASP by Application (2020-2031) & (US$/Kg)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Iohexol Growth Accelerators and Market Barriers
Table 40. North America Iohexol Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Iohexol Sales (MT) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Iohexol Growth Accelerators and Market Barriers
Table 43. Europe Iohexol Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Iohexol Sales (MT) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Iohexol Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Iohexol Sales (MT) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Iohexol Growth Accelerators and Market Barriers
Table 48. Southeast Asia Iohexol Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Iohexol Investment Opportunities and Key Challenges
Table 50. Central and South America Iohexol Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Iohexol Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Iohexol Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Zhejiang Hichi Pharmaceutical Corporation Information
Table 54. Zhejiang Hichi Pharmaceutical Description and Major Businesses
Table 55. Zhejiang Hichi Pharmaceutical Product Models, Descriptions and Specifications
Table 56. Zhejiang Hichi Pharmaceutical Capacity, Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 57. Zhejiang Hichi Pharmaceutical Sales Value Proportion by Product in 2024
Table 58. Zhejiang Hichi Pharmaceutical Sales Value Proportion by Application in 2024
Table 59. Zhejiang Hichi Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 60. Zhejiang Hichi Pharmaceutical Iohexol SWOT Analysis
Table 61. Zhejiang Hichi Pharmaceutical Recent Developments
Table 62. GE Healthcare Corporation Information
Table 63. GE Healthcare Description and Major Businesses
Table 64. GE Healthcare Product Models, Descriptions and Specifications
Table 65. GE Healthcare Capacity, Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 66. GE Healthcare Sales Value Proportion by Product in 2024
Table 67. GE Healthcare Sales Value Proportion by Application in 2024
Table 68. GE Healthcare Sales Value Proportion by Geographic Area in 2024
Table 69. GE Healthcare Iohexol SWOT Analysis
Table 70. GE Healthcare Recent Developments
Table 71. Zhejiang Starry Pharmaceutical Corporation Information
Table 72. Zhejiang Starry Pharmaceutical Description and Major Businesses
Table 73. Zhejiang Starry Pharmaceutical Product Models, Descriptions and Specifications
Table 74. Zhejiang Starry Pharmaceutical Capacity, Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 75. Zhejiang Starry Pharmaceutical Sales Value Proportion by Product in 2024
Table 76. Zhejiang Starry Pharmaceutical Sales Value Proportion by Application in 2024
Table 77. Zhejiang Starry Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 78. Zhejiang Starry Pharmaceutical Iohexol SWOT Analysis
Table 79. Zhejiang Starry Pharmaceutical Recent Developments
Table 80. Otsuka Chemicals Corporation Information
Table 81. Otsuka Chemicals Description and Major Businesses
Table 82. Otsuka Chemicals Product Models, Descriptions and Specifications
Table 83. Otsuka Chemicals Capacity, Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 84. Otsuka Chemicals Sales Value Proportion by Product in 2024
Table 85. Otsuka Chemicals Sales Value Proportion by Application in 2024
Table 86. Otsuka Chemicals Sales Value Proportion by Geographic Area in 2024
Table 87. Otsuka Chemicals Iohexol SWOT Analysis
Table 88. Otsuka Chemicals Recent Developments
Table 89. Justesa Imagen Corporation Information
Table 90. Justesa Imagen Description and Major Businesses
Table 91. Justesa Imagen Product Models, Descriptions and Specifications
Table 92. Justesa Imagen Capacity, Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 93. Justesa Imagen Sales Value Proportion by Product in 2024
Table 94. Justesa Imagen Sales Value Proportion by Application in 2024
Table 95. Justesa Imagen Sales Value Proportion by Geographic Area in 2024
Table 96. Justesa Imagen Iohexol SWOT Analysis
Table 97. Justesa Imagen Recent Developments
Table 98. Beijing Beilu Pharmaceutical Corporation Information
Table 99. Beijing Beilu Pharmaceutical Description and Major Businesses
Table 100. Beijing Beilu Pharmaceutical Product Models, Descriptions and Specifications
Table 101. Beijing Beilu Pharmaceutical Capacity, Sales (MT), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
Table 102. Beijing Beilu Pharmaceutical Recent Developments
Table 103. Key Raw Materials Distribution
Table 104. Raw Materials Key Suppliers
Table 105. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 106. Milestones in Production Technology Evolution
Table 107. Distributors List
Table 108. Market Trends and Market Evolution
Table 109. Market Drivers and Opportunities
Table 110. Market Challenges, Risks, and Restraints
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Iohexol Product Picture
Figure 2. Global Iohexol Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Original Drug Product Picture
Figure 4. Generic Drug Product Picture
Figure 5. Global Iohexol Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Contrast Agents
Figure 7. Diagnostic Agents
Figure 8. Others
Figure 9. Iohexol Report Years Considered
Figure 10. Global Iohexol Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Iohexol Revenue (2020-2031) & (US$ Million)
Figure 12. Global Iohexol Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Iohexol Revenue Market Share by Region (2020-2031)
Figure 14. Global Iohexol Sales (2020-2031) & (MT)
Figure 15. Global Iohexol Sales (CAGR) by Region (2020-2031) (MT)
Figure 16. Global Iohexol Sales Market Share by Region (2020-2031)
Figure 17. Global Iohexol Capacity, Production and Utilization (2020-2031) & (MT)
Figure 18. Global Iohexol Production Trend by Region (2020-2031) (MT)
Figure 19. Global Iohexol Production Market Share by Region (2020-2031)
Figure 20. Production Capacity Enablers & Constraints
Figure 21. Iohexol Production Growth Rate in North America (2020-2031) & (MT)
Figure 22. Iohexol Production Growth Rate in Europe (2020-2031) & (MT)
Figure 23. Iohexol Production Growth Rate in China (2020-2031) & (MT)
Figure 24. Top 5 and Top 10 Manufacturers Iohexol Sales Volume Market Share in 2024
Figure 25. Global Iohexol Revenue Market Share Ranking (2024)
Figure 26. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 27. Original Drug Revenue Market Share by Manufacturer in 2024
Figure 28. Generic Drug Revenue Market Share by Manufacturer in 2024
Figure 29. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 30. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 31. Global Iohexol Sales Market Share by Type (2020-2031)
Figure 32. Global Iohexol Revenue Market Share by Type (2020-2031)
Figure 33. Global Iohexol Sales Market Share by Application (2020-2031)
Figure 34. Global Iohexol Revenue Market Share by Application (2020-2031)
Figure 35. North America Iohexol Sales YoY (2020-2031) & (MT)
Figure 36. North America Iohexol Revenue YoY (2020-2031) & (US$ Million)
Figure 37. North America Top 5 Manufacturers Iohexol Sales Revenue (US$ Million) in 2024
Figure 38. North America Iohexol Sales Volume (MT) by Type (2020- 2031)
Figure 39. North America Iohexol Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 40. North America Iohexol Sales Volume (MT) by Application (2020-2031)
Figure 41. North America Iohexol Sales Revenue (US$ Million) by Application (2020-2031)
Figure 42. US Iohexol Revenue (2020-2031) & (US$ Million)
Figure 43. Canada Iohexol Revenue (2020-2031) & (US$ Million)
Figure 44. Mexico Iohexol Revenue (2020-2031) & (US$ Million)
Figure 45. Europe Iohexol Sales YoY (2020-2031) & (MT)
Figure 46. Europe Iohexol Revenue YoY (2020-2031) & (US$ Million)
Figure 47. Europe Top 5 Manufacturers Iohexol Sales Revenue (US$ Million) in 2024
Figure 48. Europe Iohexol Sales Volume (MT) by Type (2020-2031)
Figure 49. Europe Iohexol Sales Revenue (US$ Million) by Type (2020-2031)
Figure 50. Europe Iohexol Sales Volume (MT) by Application (2020-2031)
Figure 51. Europe Iohexol Sales Revenue (US$ Million) by Application (2020-2031)
Figure 52. Asia-Pacific Iohexol Sales YoY (2020-2031) & (MT)
Figure 53. Asia-Pacific Iohexol Revenue YoY (2020-2031) & (US$ Million)
Figure 54. Asia-Pacific Top 8 Manufacturers Iohexol Sales Revenue (US$ Million) in 2024
Figure 55. Asia-Pacific Iohexol Sales Volume (MT) by Type (2020- 2031)
Figure 56. Asia-Pacific Iohexol Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 57. Asia-Pacific Iohexol Sales Volume (MT) by Application (2020-2031)
Figure 58. Asia-Pacific Iohexol Sales Revenue (US$ Million) by Application (2020-2031)
Figure 59. Indonesia Iohexol Revenue (2020-2031) & (US$ Million)
Figure 60. Japan Iohexol Revenue (2020-2031) & (US$ Million)
Figure 61. South Korea Iohexol Revenue (2020-2031) & (US$ Million)
Figure 62. China Taiwan Iohexol Revenue (2020-2031) & (US$ Million)
Figure 63. India Iohexol Revenue (2020-2031) & (US$ Million)
Figure 64. Central and South America Iohexol Sales YoY (2020-2031) & (MT)
Figure 65. Central and South America Iohexol Revenue YoY (2020-2031) & (US$ Million)
Figure 66. Central and South America Top 5 Manufacturers Iohexol Sales Revenue (US$ Million) in 2024
Figure 67. Central and South America Iohexol Sales Volume (MT) by Type (2021-2031)
Figure 68. Central and South America Iohexol Sales Revenue (US$ Million) by Type (2020-2031)
Figure 69. Central and South America Iohexol Sales Volume (MT) by Application (2020-2031)
Figure 70. Central and South America Iohexol Sales Revenue (US$ Million) by Application (2020-2031)
Figure 71. Brazil Iohexol Revenue (2020-2025) & (US$ Million)
Figure 72. Argentina Iohexol Revenue (2020-2025) & (US$ Million)
Figure 73. Middle East, and Africa Iohexol Sales YoY (2020-2031) & (MT)
Figure 74. Middle East and Africa Iohexol Revenue YoY (2020-2031) & (US$ Million)
Figure 75. Middle East and Africa Top 5 Manufacturers Iohexol Sales Revenue (US$ Million) in 2024
Figure 76. Middle East and Africa Iohexol Sales Volume (MT) by Type (2021-2031)
Figure 77. South America Iohexol Sales Revenue (US$ Million) by Type (2020-2031)
Figure 78. Middle East and Africa Iohexol Sales Volume (MT) by Application (2020-2031)
Figure 79. Middle East and Africa Iohexol Sales Revenue (US$ Million) by Application (2020-2031)
Figure 80. GCC Countries Iohexol Revenue (2020-2025) & (US$ Million)
Figure 81. Turkey Iohexol Revenue (2020-2025) & (US$ Million)
Figure 82. Egypt Iohexol Revenue (2020-2025) & (US$ Million)
Figure 83. South Africa Iohexol Revenue (2020-2025) & (US$ Million)
Figure 84. Iohexol Industry Chain Mapping
Figure 85. Regional Iohexol Manufacturing Base Distribution (%)
Figure 86. Iohexol Production Process
Figure 87. Regional Iohexol Production Cost Structure
Figure 88. Channels of Distribution (Direct Vs Distribution)
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 6.9% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
Which companies rank high in the global Iohexol market?
What is the annual compound growth rate of the global Iohexol market size from 2025 to 2031?
What was the global market size of Iohexol in 2031?
What was the global market size of Iohexol in 2025?
Related Reports
Global Iohexol Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Iohexol market size was US$ 719 million in 2025 and is forecast to reach a readjusted size of US$ 1140 million by 2032 with a CAGR of 6.9% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 76
USD 4250.00
(Single User License)
Global Iohexol Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Iohexol market is projected to grow from US$ 719 million in 2025 to US$ 1140 million by 2032, at a CAGR of 6.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 142
USD 4900.00
(Single User License)
Iohexol- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Iohexol was estimated to be worth US$ 719 million in 2025 and is projected to reach US$ 1140 million, growing at a CAGR of 6.9% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 95
USD 3950.00
(Single User License)
Global Iohexol Market Research Report 2026
The global Iohexol market was valued at US$ 719 million in 2025 and is anticipated to reach US$ 1140 million by 2032, at a CAGR of 6.9% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 132
USD 2900.00
(Single User License)
Iohexol - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Iohexol was estimated to be worth US$ 674 million in 2024 and is forecast to a readjusted size of US$ 1073 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Published Date: 2025-10-29
Pages: 109
USD 3950.00
(Single User License)
Global Iohexol Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Iohexol market size was US$ 674 million in 2024 and is forecast to a readjusted size of US$ 1073 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Published Date: 2025-10-29
Pages: 77
USD 4250.00
(Single User License)
Global Iohexol Market Research Report 2025
The global market for Iohexol was valued at US$ 674 million in the year 2024 and is projected to reach a revised size of US$ 1073 million by 2031, growing at a CAGR of 6.9% during the forecast period.
Published Date: 2025-10-29
Pages: 93
USD 2900.00
(Single User License)
Iohexol- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Iohexol was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 95
USD 3950.00
(Single User License)
Global Iohexol Market Research Report 2024
Iohexol (CAS 66108-95-0)
Published Date: 2024-01-31
Pages: 85
USD 2900.00
(Single User License)
Iohexol - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Iohexol (CAS 66108-95-0)
Published Date: 2024-01-16
Pages: 98
USD 3950.00
(Single User License)
Global Iohexol Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Iohexol market size was US$ 719 million in 2025 and is forecast to reach a readjusted size of US$ 1140 million by 2032 with a CAGR of 6.9% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 76
USD 4250.00 (Single User License)Global Iohexol Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Iohexol market is projected to grow from US$ 719 million in 2025 to US$ 1140 million by 2032, at a CAGR of 6.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 142
USD 4900.00 (Single User License)Iohexol- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Iohexol was estimated to be worth US$ 719 million in 2025 and is projected to reach US$ 1140 million, growing at a CAGR of 6.9% from 2026 to 2032.
Published: 2026-03-05
Pages: 95
USD 3950.00 (Single User License)Global Iohexol Market Research Report 2026
The global Iohexol market was valued at US$ 719 million in 2025 and is anticipated to reach US$ 1140 million by 2032, at a CAGR of 6.9% from 2026 to 2032.
Published: 2026-03-05
Pages: 132
USD 2900.00 (Single User License)Iohexol - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Iohexol was estimated to be worth US$ 674 million in 2024 and is forecast to a readjusted size of US$ 1073 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Published: 2025-10-29
Pages: 109
USD 3950.00 (Single User License)Global Iohexol Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Iohexol market size was US$ 674 million in 2024 and is forecast to a readjusted size of US$ 1073 million by 2031 with a CAGR of 6.9% during the forecast period 2025-2031.
Published: 2025-10-29
Pages: 77
USD 4250.00 (Single User License)Global Iohexol Market Research Report 2025
The global market for Iohexol was valued at US$ 674 million in the year 2024 and is projected to reach a revised size of US$ 1073 million by 2031, growing at a CAGR of 6.9% during the forecast period.
Published: 2025-10-29
Pages: 93
USD 2900.00 (Single User License)Iohexol- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Iohexol was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 95
USD 3950.00 (Single User License)Global Iohexol Market Research Report 2024
Iohexol (CAS 66108-95-0)
Published: 2024-01-31
Pages: 85
USD 2900.00 (Single User License)Iohexol - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Iohexol (CAS 66108-95-0)
Published: 2024-01-16
Pages: 98
USD 3950.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now